P450: Difference between revisions
ClaireLewis (talk | contribs) No edit summary |
(Add See Also and References) |
||
| Line 45: | Line 45: | ||
*Chronic EtOH | *Chronic EtOH | ||
*[[Tobacco]] smoking | *[[Tobacco]] smoking | ||
==See Also== | |||
*[[Drug levels]] | |||
*[[Drug interactions]] | |||
*[[Pharmacology]] | |||
==References== | |||
<references/> | |||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
Latest revision as of 09:13, 22 March 2026
Background
Antimicrobials
Avoid /P450 Inhibitors
- Quinolones, especially levofloxacin
- Macrolides, especially erythromycin
- Bactrim and sulfonamides
- Flagyl
- Nafcillin, oxacillin
Use
Significant P450 Inhibitors in General
- Grapefruit juice
- Valproate]
- INH
- Protease inhibitors (-navir, i.e. ritonavir)
- SSRIs, except escitalopram
- Amiodarone
- Fluoroquinolones
- Sulfonamides
- Macrolides
- Cimetidine
- Omeprazole
- Ketoconazole
- Acute ETOH
Significant P450 Inducers in General
- Phenytoin
- Carbamazepine
- Ethosuximide
- Quinidine/quinine
- Rifampin
- Griseofulvin
- Glucocorticoids
- Barbiturates
- St. John's wort
- Chronic EtOH
- Tobacco smoking